The views of obstetricians in the south-west of England on the use of prostaglandins and syntocinon in VBAC.
The aim of our study was to explore the views of consultant obstetricians in the south-west of England on the use of prostaglandin and oxytocin in women undergoing vaginal birth after caesarean delivery (VBAC), and assess how the perceived risk of uterine rupture in such a cohort of women affected their practice. A postal questionnaire was sent to randomly selected consultant obstetricians in the south-west of England. The response rate from the survey was 59.2%. The study showed that the willingness of consultants to use prostaglandin in VBAC was related to their length of practice. Some 89.7% of all respondents claim they would use syntocinon for augmentation in VBAC; 75% of all the responding consultants who have been in the post for longer than 10 years claim they would not use either of the agents in VBAC. We conclude that, despite concerns about the risks of increased uterine rupture in both induction and augmentation in labour of women undergoing VBAC, our study did not seem to support the fact that obstetricians' practices are influenced by this perceived risk.
Oladipo
A
A
Department of Obstetrics and Gynaecology, Royal Cornwall Hospital, Truro, UK.
Syed
A
A
D004739:England; D005260:Female; D006801:Humans; D009774:Obstetrics; D010120:Oxytocics / Q000009:adverse effects / Q000627:therapeutic use*; D010121:Oxytocin / Q000009:adverse effects / Q000627:therapeutic use*; D010818:Practice Patterns, Physicians'; D011247:Pregnancy; D011453:Prostaglandins / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D014597:Uterine Rupture / Q000209:etiology; D016064:Vaginal Birth after Cesarean
D010120:Oxytocics; D011453:Prostaglandins; D010121:Oxytocin